Interferences of o-raffinose cross-linked hemoglobin in three methods for serum creatinine

Clinical Chemistry

Volumn 43, Issue 9, 1997, Pages 1738-1743

  Ali, Arlene C Y ^a   Mihas, Chrystina C ^a   Campbell, Janet A ^a  

^a Hemosol Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RAFFINOSE;

CONFERENCE PAPER; CREATININE BLOOD LEVEL; HEMOLYSIS; HUMAN; HYPERLIPIDEMIA; JAUNDICE; PROTEIN ANALYSIS;

EID: 0030882598     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.9.1738     Document Type: Conference Paper

References (22)

1. Click MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986:32:470-5.
2. Randall AG, Garcia-Webb P, Beilby JP. Interference by haemolysis, icterus and lipemia in assays on the Beckman Synchron CX5 and methods for correction. Ann Clin Biochem 1990:27:345-52.
3. Click MR, Ryder KW. Double trouble: hemolysis and stabilized hemoglobins (so you think you're seeing red now?) [Editorial]. Clin Chem 1993:39:1761-3.
4. Lieberthal W, Levinsky NG. Acute renal failure. In: Seidin DW, Giebisch G, eds. The kidney: physiology and pathophysiology. New York: Raven Press, 1992:3181-212.
5. Goldstein MB. Acute renal failure. Med Clin North Am 1983;67: 1325-41.
6. Bidani A, Churchill PC. Acute renal failure. Disease-A-Month 1989; February:63-132.
7. Savitsky JP, Doczi J, Black J, Arnold JD. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978;23:73-80.
8. Palier MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 1988;255: F539-44.
9. Nath KA, Balla J, Croatt AJ, Vercellotti GM. Heme protein-mediated renal injury: a protective role for 21-aminosteroids in vitro and in vivo. Kidney Int 1995:47:592-602.
10. Hsia JC. Pasteurizable, freeze-driable hemoglobin-based blood substitute. US Patent 4,857,636,1989.
11. Hsia JC. o-Raffinose polymerized hemoglobin as a red blood cell substitute [Abstract]. Biomater Artif Cells Immobilization Biotechnol 1991:19:402.
12. Jay DW, Provasek D. Characterization and mathematical correction of hemolysis interference in selected Hitachi 717 assays. Clin Chem 1993:39:1804-10.
13. Ali ACY, Campbell JA. Interference of o-raffinose cross-linked hemoglobin with routine Hitachi 717 assays. Clin Chem 1997;43: 1794-6.
14. Takahashi T, Iwasaki K, Malchesky PS, Harasaki H, Emoto H, Goldcamp JB, et al. Effects of a single-dose infusion of pyridoxylated-hemoglobin conjugate solution on canine renal function. Artif Organs 1991:15:462-73.
15. Keipert PE, Gomez CL, Gonzales A, MacDonald VW, Hess JR, Winslow RM. Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med 1994:123:701-11.
16. Viele M, Weiskopf RB, Fisher D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology 1997:86:848-58.
17. Keipert PE, Gomez CL, Gonzales A, Macdonald VW, Winslow RM. The role of the kidneys in the excretion of chemically modified hemoglobins. Biomater Artif Cells Immobilization Biotechnol 1992:20:737-45.
18. Fraser CG. Acceptable analytical error: a different opinion [Letter]. Clin Chem 1989;35:1553-4.
19. Fraser CG, Cummings ST, Wilkinson SP, Neville RG, Knox JDE, Ho O, MacWalter RS. Biological variability of 26 clinical chemistry analytes in elderly people. Clin Chem 1989:35:783-6.
20. Hölzel WGE. Intra-individual variation of some analytes in serum of patients with chronic renal failure. Clin Chem 1987;33:670-3.
21. Gowans EMS, Fraser CG. Biological variation of serum and urine creatinine and creatinine clearance: ramifications for interpretation of results and patient care. Ann Clin Biochem 1988;25:259-63.
22. Spencer K. Analytical reviews in clinical biochemistry: the estimation of creatinine. Ann Clin Biochem 1986:23:1-25.